ArticleACR open rheumatology2025

Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Afimetoran, a Toll-Like Receptor 7 and 8 Inhibitor, in Patients With Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study.

Fareeda Hosein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.